EUVIMEDEUVIMED entdecken
Crossref

Effect of medium cut‐off membranes on Pentosidine and N‐(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients

Neriman Sıla Koç iD, Hasan Yeter iD, Tolga Yıldırım, Yunus Erdem, Rahmi Yılmaz

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Neriman Sıla Koç und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Harran University, Şanlıurfa, Turkey. Hauptthemen laut MEDLINE: Lysine, Renal Dialysis, Arginine, Glycation End Products, Advanced. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Turkish Society of Hypertension and Renal Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients on hemodialysis, especially with diabetes, face elevated cardiovascular events. A major contributor to complications associated with diabetes is advanced glycation end products (AGEs). Removing these compounds is challenging in traditional hemodialysis. Medium‐cut‐off (MCO) membranes potentially remove toxins without significant albumin loss. This study explored how MCO membranes impact AGEs levels in uncontrolled diabetic patients undergoing hemodialysis.

Methods

Sixteen patients received MCO membrane dialysis, while others used high‐flux (HF) membranes. After 12 sessions, the dialyzers were switched, totaling 24 sessions. Blood samples at trial initiation (T0), session 12 (T1) and session 24 (T2) tested for CML, Pentosidine, laboratory parameters.

Results

Switching dialyzers showed increased albumin with MCO‐to‐HF and decreased with HF‐to‐MCO, albeit nonsignificant ( p = 0.5/ p = 0.1). Patients on MCO had lower albumin levels than HF ( p = 0.03/ p = 0.6, respectively). Hemodialysis with MCO demonstrated lower levels of CML/Pentosidine compared to HF ( p = 0.09/ p = 0.9 for CML; p = 0.04/ p = 0.3 for Pentosidine). Transitioning to HF led to elevated levels ( p = 0.4/ p = 0.09 for CML; p = 0.3/ p = 0.07 for Pentosidine).

Conclusion

MCO dialysis in diabetic individuals notably reduces AGE levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysineRenal DialysisArginineGlycation End Products, AdvancedMembranes, ArtificialHumansMaleFemaleMiddle AgedAgedDiabetes Mellitus

Stichwörter der Autor:innen

advanced glycation end productshemodialysismedium cut‐off membrane

Substanzen

pentosidineLysineArginineN(6)-carboxymethyllysineGlycation End Products, AdvancedMembranes, Artificial

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Harran University, Şanlıurfa, Turkey.
  • Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Hacettepe University, Ankara, Turkey.

ORCID-Profile: Neriman Sıla Koç, Hasan Yeter

Förderung

  • Turkish Society of Hypertension and Renal Diseases

Zitieren

APA

Koç, N. S., Yeter, H., Yıldırım, T., Erdem, Y., & Yılmaz, R. (2024). Effect of medium cut‐off membranes on Pentosidine and N‐(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14126

Vancouver

Koç NS, Yeter H, Yıldırım T, Erdem Y, Yılmaz R. Effect of medium cut‐off membranes on Pentosidine and N‐(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14126

BibTeX
@article{Ko2024,
  author = {Koç, Neriman Sıla and Yeter, Hasan and Yıldırım, Tolga and Erdem, Yunus and Yılmaz, Rahmi},
  title = {Effect of medium cut‐off membranes on Pentosidine and N‐(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14126}
}
Kostenlos starten →